Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Miguel A.G. Mendoza-Meléndez"'
Autor:
Stefanny Cornejo-Hernandez, Mayra C. Galena-Hernández, Víctor H. Rodríguez-González, Wendy R.A. Martínez-Torres, Yailin F. Velásquez-Palacios, Ashley Ramírez-Olguín, Juan S. García-Hernández, Miguel A.G. Mendoza-Meléndez, Eira Cerda-Reyes
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101428- (2024)
Introduction and Objectives: Hepatocellular carcinoma (HCC) ranks sixth among tumors, the third cause of death worldwide and accounts for 85-90% of primary liver tumors. Recently, the use of immunotherapy as first-line treatment offers a survival of
Externí odkaz:
https://doaj.org/article/623677e575314774b36b2a4802e23b4c
Autor:
Stefanny Cornejo-Hernandez, Mayra C. Galena-Hernández, Blanca Zapote-Hernández, Itzia Verduzco-Flores, Salvador Amezquita-Pérez, Erika Santiago-González, Yailin F. Velasquez-Palacios, Juan S. García-Hernández, Miguel A.G. Mendoza-Meléndez, Eira Cerda-Reyes
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101440- (2024)
Introduction and Objectives: Hepatocellular carcinoma (HCC) occupies the third cause of mortality worldwide. 10% of patients receive curative therapy. There are loco-regional therapies to improve patient survival such as (TACE) and radioembolization
Externí odkaz:
https://doaj.org/article/f4c7e1a3ba1442109b96ef0434e2bdeb